BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1186 related articles for article (PubMed ID: 29642940)

  • 21. Alterations, Interactions, and Diagnostic Potential of Gut Bacteria and Viruses in Colorectal Cancer.
    Gao R; Zhu Y; Kong C; Xia K; Li H; Zhu Y; Zhang X; Liu Y; Zhong H; Yang R; Chen C; Qin N; Qin H
    Front Cell Infect Microbiol; 2021; 11():657867. PubMed ID: 34307189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbiome analysis reveals universal diagnostic biomarkers for colorectal cancer across populations and technologies.
    Zhang H; Wu J; Ji D; Liu Y; Lu S; Lin Z; Chen T; Ao L
    Front Microbiol; 2022; 13():1005201. PubMed ID: 36406447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis.
    Conde-Pérez K; Aja-Macaya P; Buetas E; Trigo-Tasende N; Nasser-Ali M; Rumbo-Feal S; Nión P; Arribas EM; Estévez LS; Otero-Alén B; Noguera JF; Concha Á; Pardiñas-López S; Carda-Diéguez M; Gómez-Randulfe I; Martínez-Lago N; Ladra S; Aparicio LMA; Bou G; Mira Á; Vallejo JA; Poza M
    Mol Oncol; 2024 May; 18(5):1093-1122. PubMed ID: 38366793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxic T-Cell Trafficking Chemokine Profiles Correlate With Defined Mucosal Microbial Communities in Colorectal Cancer.
    Zhang J; Tao J; Gao RN; Wei ZY; He YS; Ren CY; Li QC; Liu YS; Wang KW; Yang G; Qian C; Chen JH
    Front Immunol; 2021; 12():715559. PubMed ID: 34539647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer.
    Kwong TNY; Wang X; Nakatsu G; Chow TC; Tipoe T; Dai RZW; Tsoi KKK; Wong MCS; Tse G; Chan MTV; Chan FKL; Ng SC; Wu JCY; Wu WKK; Yu J; Sung JJY; Wong SH
    Gastroenterology; 2018 Aug; 155(2):383-390.e8. PubMed ID: 29729257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease-associated gut microbiome and critical metabolomic alterations in patients with colorectal cancer.
    Zhang H; Jin K; Xiong K; Jing W; Pang Z; Feng M; Cheng X
    Cancer Med; 2023 Jul; 12(14):15720-15735. PubMed ID: 37260140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential of fecal microbiota for detection and postoperative surveillance of colorectal cancer.
    Yao Q; Tang M; Zeng L; Chu Z; Sheng H; Zhang Y; Zhou Y; Zhang H; Jiang H; Ye M
    BMC Microbiol; 2021 May; 21(1):156. PubMed ID: 34044781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enterotypical Prevotella and three novel bacterial biomarkers in preoperative stool predict the clinical outcome of colorectal cancer.
    Huh JW; Kim MJ; Kim J; Lee HG; Ryoo SB; Ku JL; Jeong SY; Park KJ; Kim D; Kim JF; Park JW
    Microbiome; 2022 Nov; 10(1):203. PubMed ID: 36443754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aging characteristics of colorectal cancer based on gut microbiota.
    Wu Y; Zhuang J; Zhang Q; Zhao X; Chen G; Han S; Hu B; Wu W; Han S
    Cancer Med; 2023 Sep; 12(17):17822-17834. PubMed ID: 37548332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer.
    Rezasoltani S; Sharafkhah M; Asadzadeh Aghdaei H; Nazemalhosseini Mojarad E; Dabiri H; Akhavan Sepahi A; Modarressi MH; Feizabadi MM; Zali MR
    J Microbiol Methods; 2018 Dec; 155():82-88. PubMed ID: 30439465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer.
    Coker OO; Nakatsu G; Dai RZ; Wu WKK; Wong SH; Ng SC; Chan FKL; Sung JJY; Yu J
    Gut; 2019 Apr; 68(4):654-662. PubMed ID: 30472682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
    Huh JW; Roh TY
    BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study.
    Zhang Y; Yu X; Yu E; Wang N; Cai Q; Shuai Q; Yan F; Jiang L; Wang H; Liu J; Chen Y; Li Z; Jiang Q
    BMC Microbiol; 2018 Aug; 18(1):92. PubMed ID: 30157754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial community structure alterations within the colorectal cancer gut microbiome.
    Loftus M; Hassouneh SA; Yooseph S
    BMC Microbiol; 2021 Mar; 21(1):98. PubMed ID: 33789570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metagenomic analysis of the fecal microbiome in colorectal cancer patients compared to healthy controls as a function of age.
    Kharofa J; Apewokin S; Alenghat T; Ollberding NJ
    Cancer Med; 2023 Feb; 12(3):2945-2957. PubMed ID: 36056757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.
    John Kenneth M; Tsai HC; Fang CY; Hussain B; Chiu YC; Hsu BM
    J Adv Res; 2023 Oct; 52():45-57. PubMed ID: 36596411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metagenomics analysis reveals universal signatures of the intestinal microbiota in colorectal cancer, regardless of regional differences.
    Berbert L; Santos A; Magro DO; Guadagnini D; Assalin HB; Lourenço LH; Martinez CAR; Saad MJA; Coy CSR
    Braz J Med Biol Res; 2022; 55():e11832. PubMed ID: 35293551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal cancer microbiome programs DNA methylation of host cells by affecting methyl donor metabolism.
    Liu Z; Zhang Q; Zhang H; Yi Z; Ma H; Wang X; Wang J; Liu Y; Zheng Y; Fang W; Huang P; Liu X
    Genome Med; 2024 Jun; 16(1):77. PubMed ID: 38840170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes.
    Nakatsu G; Zhou H; Wu WKK; Wong SH; Coker OO; Dai Z; Li X; Szeto CH; Sugimura N; Lam TY; Yu AC; Wang X; Chen Z; Wong MC; Ng SC; Chan MTV; Chan PKS; Chan FKL; Sung JJ; Yu J
    Gastroenterology; 2018 Aug; 155(2):529-541.e5. PubMed ID: 29689266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-kingdom microbial signatures in excess body weight colorectal cancer based on global metagenomic analysis.
    Zhu X; Xu P; Zhu R; Gao W; Yin W; Lan P; Zhu L; Jiao N
    Commun Biol; 2024 Jan; 7(1):24. PubMed ID: 38182885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.